ESTRELLA IMMUNOPHARMA, INC. Increase (Decrease) in Prepaid Expenses, Other
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Increase (Decrease) in Prepaid Expenses, Other of $1.50 million for the 6-month period ending 2024-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-03-18
- ESTRELLA IMMUNOPHARMA, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2024-12-31 was $0.00.
- ESTRELLA IMMUNOPHARMA, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2024-09-30 was $1.50M.
- ESTRELLA IMMUNOPHARMA, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2024-03-31 was $3.50M.
- ESTRELLA IMMUNOPHARMA, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2022-09-30 was -$833.33K.
- ESTRELLA IMMUNOPHARMA, INC. increase (decrease) in prepaid expenses, other for fiscal 2023 was -$833.33K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2026-03-18 | $1.50M 10-K · filed 2026-03-18 | ||
| 2024-09-30 | $1.50M 10-Q · filed 2024-11-14 | $1.50M 10-Q · filed 2025-11-12 | ||
| 2024-03-31 | $3.50M 10-Q · filed 2025-05-14 | |||
| 2023-06-30 | -$833.33K 10-K · filed 2024-09-27 | |||
| 2022-09-30 | -$833.33K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |